69 Best Biotech Startups in Spain to Watch in 2024

Inbrain Neuroelectronics is a developer of brain-computer interface therapeutics (BCI-Tx founded in 2020 by Carolina Aguilar.

Total Raised: $68.10M

Last Funding: $50.00M (Series B)

Drug discovery and development platform.

Total Raised: $8.65M

Last Funding: $1.00M (Seed)

Clinical stage treatment for Myotonic Dystrophy Type 1

Total Raised: $46.32M

Last Funding: $46.32M (Series B)

Developer of diagnostic and therapeutic solutions for cognitive disorders and neurodegenerative diseases.

Total Raised: $1.64M

Last Funding: $1.64M (Seed)

Biotechnological solutions for menopause treatment.

Total Raised: $1.02M

Last Funding: $1.02M (Seed)

Drugs discovery platform for orphan diseases.

Total Raised: $104.95M

Last Funding: $54.74M (Series C)

Therapeutic biologics platform to treat metastatic cancer.

Total Raised: $35.65M

Last Funding: $33.97M (Series A)

Colorectal cancer test platform.

Total Raised: $93.03M

Last Funding: $93.03M (Series B)

Platform for detection, evolution and treatment for complex oncology.

Total Raised: $0.88M

Last Funding: $0.88M (Seed)

Drug developer for Acute Ischemic Stroke (AIS).

Total Raised: $1.84M

Last Funding: $1.84M (Seed)

Clinical-stage cancer detection.

Total Raised: $1.40M

Last Funding: $1.40M (Seed)

Early detection of Alzheimer's disease (AD) technology.

Total Raised: $6.03M

Last Funding: $5.80M (Series A)

Active ingredient producer from plant stem cells for the cosmetics industry.

Total Raised: $6.54M

Last Funding: $2.50M (Seed)

Preventive genomic medicine developer.

Total Raised: $20.00M

Last Funding: $20.00M (Series A)

Proteins and enzymes for individual protein, nutrition, and healthcare applications.

Total Raised: $16.09M

Last Funding: $16.09M (Series A)

Platform for discovering new, innovative treatments to help patients.

Total Raised: $3.40M

Last Funding: $3.40M (Unknown)

Therapies for leukaemia based on CAR–T.

Total Raised: $7.37M

Last Funding: $7.37M (Seed)

Creator of gene writing tools to boost the efficiency and safety of advanced therapies.

Total Raised: $11.40M

Last Funding: $11.40M (Series A)

Research and development of innovative cancer treatments using protein nanoparticles for clinical phases.

Total Raised: $1.13M

Last Funding: $1.13M (Seed)

Biotech developing urology treatments.

Total Raised: $5.90M

Last Funding: $0.89M (Seed)

Therapeutics treatment for strokes and brain injury.

Total Raised: $5.51M

Last Funding: $2.80M (Series A)

Platform offering animal-free food options using biological diversity expertise.

Total Raised: $1.25M

Last Funding: $1.25M (Seed)

Cell-based fats company focused on creating healthier alternatives.

Total Raised: $14.62M

Last Funding: $14.62M (Unknown)

Pharma R&D engine focused on clinical stage treatments in the CNS field.

Total Raised: $8.10M

Last Funding: $8.10M (Series A)

Cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

Total Raised: $13.91M

Last Funding: $13.91M (Unknown)

Biopharmaceutical firm centered on the tumor microenvironment.

Total Raised: $10.28M

Last Funding: $10.28M (Unknown)

Dual SMAD Inhibiting Protein (DSIP) modulating antibody developer.

Total Raised: $4.07M

Last Funding: $4.07M (Seed)

Drug discovery company for brain and neurodegenerative conditions.

Total Raised: $5.32M

Last Funding: $5.32M (Seed)

Biotech firm focusing on creating new tools for disease monitoring and clinical evaluation.

Total Raised: $1.30M

Last Funding: $1.30M (Unknown)

Addressing “undruggable intracellular targets” in oncology

Total Raised: $1.37M

Last Funding: $1.37M (Seed)

Platform for manufacturing recombinant proteins using innovative vector-based technologies.

Total Raised: $4.52M

Last Funding: $4.52M (Unknown)

Electricty from nature.

Total Raised: $2.26M

Last Funding: $1.71M (Unknown)

Technological and clinical validation of the SimVis technology to treat presbyopia with multifocal contact lenses

Total Raised: $2.57M

Last Funding: $0.95M (Pre Seed)

Marketplace for dietary and para-pharmacy products made from Cannabis Sativa L and beekeeping.

Total Raised: $1.38M

Last Funding: $1.07M (Seed)

CDMO focused on developing and manufacturing Lentiviral vectors.

Total Raised: $3.86M

Last Funding: $3.86M (Unknown)

Early cancer detection diagnostics platform.

Total Raised: $3.76M

Last Funding: $3.76M (Unknown)

Manufacturing process creating leather from biological and recyclable materials.

Total Raised: $0.47M

Last Funding: $0.47M (Pre Seed)

Robotic physiotherapy system helps improve our quality of life.

Total Raised: $0.51M

Last Funding: $0.51M (Pre Seed)

Nanomaterials company specializing in creating and selling innovative nanoparticle materials.

Total Raised: $2.06M

Last Funding: $2.06M (Unknown)

Technology that improves health care.

Total Raised: $0.39M

Last Funding: $0.39M (Pre Seed)

Active ingredients reducing the incidence of skin cancer through research and development.

Total Raised: $1.81M

Last Funding: $1.81M (Series A)

Biopharmaceutical company developing new therapies.

Total Raised: $1.15M

Last Funding: $1.15M (Seed)

AI-driven medical imaging platform for stroke treatment.

Total Raised: $2.13M

Last Funding: $2.13M (Unknown)

Bioprocess equipment manufacturer.

Total Raised: $2.75M

Last Funding: $2.75M (Unknown)

PHARMA DISCOVERY TO KEEP THE HEART BEATING

Total Raised: $0.87M

Last Funding: $0.87M (Pre Seed)

Cardiac mapping system developed to be innovative and completely non-invasive.

Total Raised: $3.12M

Last Funding: $2.78M (Unknown)

The ultimate solution for aortic diseases

Total Raised: $0.72M

Last Funding: $0.00M (Unknown)

Therapeutic techniques development focuses on overcoming cancer resistance to enhance patient outcomes.

Total Raised: $0.57M

Last Funding: $0.57M (Seed)

Computational enzyme discovery.

Total Raised: $1.39M

Last Funding: $1.39M (Seed)

Company specializing in products that enhance soil health and boost crop productivity.

Total Raised: $1.78M

Last Funding: $1.78M (Unknown)

A biopharmaceutical platform focusing on the discovery, design, and clinical development of new MLT-based drugs.

Total Raised: $1.80M

Last Funding: $1.80M (Series A)

Urine-based breast cancer detection platform.

Total Raised: $0.54M

Last Funding: $0.54M (Seed)

A new generation of skin-regeneration products

Total Raised: $0.41M

Last Funding: $0.41M (Pre Seed)

Supercomputing software that helps with diagnosis of breast cancer.

Total Raised: $0.88M

Last Funding: $0.88M (Pre Seed)

Technology company specializing in research and development in renewable energy.

Total Raised: $0.56M

Last Funding: $0.56M (Series A)

Nanotechnology-based solutions for medical treatments.

Total Raised: $0.67M

Last Funding: $0.67M (Unknown)

Software company specialized in the biomedical field.

Total Raised: $1.18M

Last Funding: $1.18M (Unknown)

A precise and portable in-vitro device that brings efficiency to the hematological diseases diagnostics with a single blood drop.

Total Raised: $0.40M

Last Funding: $0.40M (Pre Seed)

A new generation of materials for biomedical devices that improve the quality of life and an efficient medicine.

Total Raised: $0.33M

Last Funding: $0.00M (Unknown)

Wearable soft robotics for neural recovery

Total Raised: $0.85M

Last Funding: $0.85M (Pre Seed)

CRO specializing in new enzybiotics development and preclinical services using zebrafish.

Total Raised: $0.89M

Last Funding: $0.89M (Pre Seed)

Nutricosmetic product developer focused on creating custom solutions for sensitive skin.

Total Raised: $0.23M

Last Funding: $0.23M (Pre Seed)

B2B SaaS powered by AI that makes crop predictions (best harvesting time, plant diseases...) without IoT

Total Raised: $0.32M

Last Funding: $0.32M (Pre Seed)

Sampling service provider specializing in non-clinical and clinical needs.

Total Raised: $0.31M

Last Funding: $0.31M (Pre Seed)

Ceramic membrane modules and facilities for separating oxygen from air.

Total Raised: $0.23M

Last Funding: $0.23M (Pre Seed)

Instrumentation provider specializing in acoustic resonator characterization.

Platform focused on preventing and managing type 2 diabetes.

Last Funding: $0.00M (Unknown)

The intein platform revolutionizing genetic disease treatment.

Last Funding: $0.00M (Series A)

Platform simplifying interactions between humans and machines using voice and cognitive technologies.